Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-31
2006-01-31
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S210000
Reexamination Certificate
active
06992091
ABSTRACT:
The present application describes N-ureidoalkyl piperidines as modulators of chemokine receptors, or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
REFERENCES:
patent: 5668151 (1997-09-01), Poindexter et al.
patent: 6323334 (2001-11-01), Kingsbury et al.
patent: 6331541 (2001-12-01), Ko et al.
patent: 6339087 (2002-01-01), Gong et al.
patent: 6486180 (2002-11-01), Ko et al.
patent: 6638950 (2003-10-01), Duncia et al.
patent: 6770650 (2004-08-01), Gong et al.
patent: WO 93/06108 (1993-04-01), None
patent: WO 94/22846 (1994-10-01), None
patent: WO 95/13069 (1995-05-01), None
patent: WO 97/27752 (1997-08-01), None
patent: WO 98/25604 (1998-06-01), None
patent: WO 99/04794 (1999-02-01), None
patent: 903349 (1999-03-01), None
patent: WO 00/35453 (2000-06-01), None
Mammen et al. “Preparation of biphenyl derivatives . . . ” CA 141:225161 (2004).
Duncia John V.
Gardner Daniel S.
Santella Joseph B.
Bristol--Myers Squibb Company
Chang Celia
VanAtten Mary
LandOfFree
N-ureidoalkyl-piperidines as modulators of chemokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-ureidoalkyl-piperidines as modulators of chemokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-ureidoalkyl-piperidines as modulators of chemokine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3554871